Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.

MLA

Cahill, Katherine N., et al. “Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-Exacerbated Respiratory Disease. A Prospective Trial.” American Journal of Respiratory and Critical Care Medicine, vol. 200, no. 6, Sept. 2019, pp. 704–11. EBSCOhost, https://doi.org/10.1164/rccm.201809-1755OC.

APA

Cahill, K. N., Cui, J., Kothari, P., Murphy, K., Raby, B. A., Singer, J., Israel, E., Boyce, J. A., & Laidlaw, T. M. (2019). Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial. American Journal of Respiratory and Critical Care Medicine, 200(6), 704–711. https://doi.org/10.1164/rccm.201809-1755OC

Chicago

Cahill, Katherine N, Jing Cui, Parul Kothari, Katherine Murphy, Benjamin A Raby, Joseph Singer, Elliot Israel, Joshua A Boyce, and Tanya M Laidlaw. 2019. “Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-Exacerbated Respiratory Disease. A Prospective Trial.” American Journal of Respiratory and Critical Care Medicine 200 (6): 704–11. doi:10.1164/rccm.201809-1755OC.